J
John R. Hurst
Researcher at University College London
Publications - 344
Citations - 16669
John R. Hurst is an academic researcher from University College London. The author has contributed to research in topics: COPD & Exacerbation. The author has an hindex of 51, co-authored 281 publications receiving 12644 citations. Previous affiliations of John R. Hurst include Royal College of Physicians & Boston University.
Papers
More filters
Journal ArticleDOI
“NEWS2” as an Objective Assessment of Hospitalised COPD Exacerbation Severity
TL;DR: The generic NEWS2 risk assessment tool, readily calculated from simple physiological data, predicts inpatient mortality and need for NIV (but not length-of-stay) at exacerbations of COPD.
Proceedings ArticleDOI
Relationships Between COPD Exacerbation Frequency And Arterial Stiffness
Anant R.C. Patel,Beverly Kowlessar,Alexander J. Mackay,Gavin C. Donaldson,Jadwiga A. Wedzicha,John R. Hurst +5 more
Journal ArticleDOI
The Impact of Re-Admissions in COPD
TL;DR: The respiratory community is failing people living with chronic obstructive pulmonary disease (COPD) by not addressing the problem of high re-admission rates following hospital treatment for exacerbations of COPD, despite evidence that exacerbations cause much of the health-care burden and costs associated with COPD.
Journal ArticleDOI
BronchUK: protocol for an observational cohort study and biobank in bronchiectasis.
Anthony De Soyza,Philip Mawson,Adam T. Hill,Stuart Elborn,Judy M. Bradley,Charles S. Haworth,Charles S. Haworth,R. Andres Floto,R. Andres Floto,Robert Wilson,Michael R. Loebinger,Mary P. Carroll,Megan Crichton,James D. Chalmers,Anita L Sullivan,Jeremy S. Brown,John R. Hurst,Jamie Duckers,Martin Kelly,John Steer,Tim Gatheral,Paul Walker,Craig Winstanley,Alistair McGuire,David W. Denning,Richard J. Q. McNally +25 more
TL;DR: BronchUK (Bronchiectasis Observational Cohort and Biobank UK) as mentioned in this paper is a multicentre, prospective, observational cohort study working collaboratively with the European Multicentre Bronchiectas Audit and Research Collaboration project.
Journal ArticleDOI
Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial
Trishul Siddharthan,Trishul Siddharthan,Suzanne L. Pollard,Suzanne L. Pollard,Peter Jackson,Nicole M Robertson,Nicole M Robertson,Adaeze C. Wosu,Nihaal Rahman,Nihaal Rahman,Roma Padalkar,Roma Padalkar,Isaac Sekitoleko,Esther Namazzi,Patricia Alupo,John R. Hurst,Robert Kalyesubula,David W. Dowdy,Robert A. Wise,Robert A. Wise,Peter J. Barnes,William Checkley,William Checkley,Bruce Kirenga +23 more
TL;DR: The Low-dose Theophylline for the Management of Biomass-associated COPD (LODOT-BCOPD) trial as discussed by the authors investigates the clinical efficacy and cost-effectiveness of low-dose theophyllines for the management of biomass-related COPD in a low-and middle-income setting.